Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Apararenone (MT-3995) is a receptor antagonist of mineralocorticoid receptor which can be used to treat non-alcoholic steatohepatitis and diabetic nephropathy.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 62.00 | |
10 mg | In stock | $ 84.00 | |
25 mg | In stock | $ 131.00 | |
50 mg | In stock | $ 189.00 | |
100 mg | In stock | $ 276.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 76.00 |
Description | Apararenone (MT-3995) is a receptor antagonist of mineralocorticoid receptor which can be used to treat non-alcoholic steatohepatitis and diabetic nephropathy. |
In vivo | A phase II clinical trial has been initiated among patients with non-alcoholic steatohepatitis (NASH) in Japan[1]. |
Synonyms | MT-3995 |
Molecular Weight | 364.39 |
Formula | C17H17FN2O4S |
CAS No. | 945966-46-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 125 mg/mL (343.04 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Apararenone 945966-46-1 Endocrinology/Hormones Glucocorticoid Receptor inhibit Inhibitor MT 3995 Mineralocorticoid Receptor MT3995 MT-3995 inhibitor